von Tobias Borgers | Aug. 20, 2019 | Boehringer
The Global “Bronchodilators” Market research report highlights the major details and provides in-depth analysis of the market along with the future growth, prospects and Industry demands analysis explores with the table of contents to analyze the situations of global...
von Tobias Borgers | Aug. 19, 2019 | Boehringer
HTF MI newly added the mRNA Vaccines & Therapeutics Market Study that gives meticulous investigation of current scenario of the Market size, share, demand, growth, trends, and forecast in the coming years. The report firstly introduced the mRNA Vaccines &...
von Tobias Borgers | Aug. 19, 2019 | Roche
Media Release Basel, 16 May 2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by...
von Tobias Borgers | Aug. 19, 2019 | Novartis
Media Release Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off. Read More Video – The future of Novartis Our future is as a leading focused medicines company, powered by data science and advanced therapy...
von Tobias Borgers | Aug. 19, 2019 | Boehringer
The Global Anticoagulants market report offers historical and forecast market data, demand, application details, price trends, and company shares of the leading Anticoagulants by geography. The report splits the market size, by volume and value, on the basis of...
von Tobias Borgers | Aug. 18, 2019 | Glaxo
Issued: London UK – LSE Announcement TESARO, an oncology-focused business acquired by GlaxoSmithKline plc (LSE/NYSE: GSK), announced today the presentation of data from the Phase 1/2 GARNET study evaluating dostarlimab in women with recurrent or advanced endometrial...
